Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HRS Moves From Successful Policy Meeting Toward Physician Guidelines

This article was originally published in The Gray Sheet

Executive Summary

The Heart Rhythm Society hopes to complete physician guidelines on managing device safety alerts by late spring 2006, according to the chair of the committee developing the guidelines, Mark Carlson, MD, Case Western Reserve University

You may also be interested in...



People In Brief

Orthofix names new CEO: Chief Operating Officer Alan Milinazzo will be promoted to the orthopedic firm's top spot effective April 1. He will replace Charles Federico, who will remain a director of Orthofix. The company has not yet named a successor to the COO position. Milinazzo joined Orthofix as its first-ever operations executive in September 2005 after three years at Medtronic, where he served as VP of its vascular, peripheral and coronary business units. He previously worked at Boston Scientific for 12 years in a variety of roles, including VP of marketing. In January, the firm hired a new general manager for their vascular business (1"The Gray Sheet" Jan. 2, 2006, p. 19)...

People In Brief

Orthofix names new CEO: Chief Operating Officer Alan Milinazzo will be promoted to the orthopedic firm's top spot effective April 1. He will replace Charles Federico, who will remain a director of Orthofix. The company has not yet named a successor to the COO position. Milinazzo joined Orthofix as its first-ever operations executive in September 2005 after three years at Medtronic, where he served as VP of its vascular, peripheral and coronary business units. He previously worked at Boston Scientific for 12 years in a variety of roles, including VP of marketing. In January, the firm hired a new general manager for their vascular business (1"The Gray Sheet" Jan. 2, 2006, p. 19)...

HRS Task Force

The Heart Rhythm Society announces creation of 14-member task force to draft recommendations for improving ICD and pacemaker postmarket surveillance and communications between manufacturers, the federal government, doctors and patients. Chaired by Mark Carlson, MD, Case Western Reserve University, and comprised of electrophysiologist professionals who belong to HRS, the group aims to make the public policy recommendations available for public comment by May 1, 2006. It will draw on suggestions made at a September conference hosted by HRS and FDA (1"The Gray Sheet" Oct. 3, 2005, p. 7)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022726

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel